Global Blood Therapeutics (GBT) – Analyst Ratings
-
Wells Fargo Downgrades Global Blood Therapeutics (GBT) to Equal Weight
-
RBC Capital Steps Aside on Global Blood Therapeutics (GBT), 'Oxbryta Beat Confirms Value; With Solid Outcome'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GBT Stock Lookup